Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("Laboratoires Fournier")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1
Export

Selection :

  • and

Lipids in cardiology. International WorkshopFERRARI, R.European heart journal. 1998, Vol 19, Num FEV, issn 0195-668X, 67 p., SUPAConference Proceedings

International workshop on lipid metabolismJACOTOT, Bernard.Atherosclerosis. 1994, Vol 110, pp S1-S91, issn 0021-9150, SUPConference Proceedings

European and American recommendations for coronary heart disease preventionWOOD, D.European heart journal. 1998, Vol 19, Num FEV, pp A12-A19, issn 0195-668X, SUPAConference Paper

Lipoprotein metabolismBEISIEGEL, U.European heart journal. 1998, Vol 19, Num FEV, pp A20-A23, issn 0195-668X, SUPAConference Paper

An overview of reverse cholesterol transportTALL, A. R.European heart journal. 1998, Vol 19, Num FEV, pp A31-A35, issn 0195-668X, SUPAConference Paper

Synthèse totale du Vinigrol : nouvelle substance naturelle, puissant inhibiteur potentiel de l'angiotensine II = Total synthesis of Vinigrol : a new natural product, a powerful potential inhibitor of angiotensin IIBellamy, François.1992, 13 p.Report

Megakaryocytes: cellular and molecular biology/3th international conference on megakaryocytes: abstracts, Dijon, FRA, July 23-27, 1989Nouvelle revue française d'hématologie. 1989, Vol 31, Num 3, pp 231-240, issn 0029-4810Conference Proceedings

Coronary heart disease risk factors in womenBROCHIER, M. L; ARWIDSON, P.European heart journal. 1998, Vol 19, Num FEV, pp A45-A52, issn 0195-668X, SUPAConference Paper

Overview of fenofibratePACKARD, C. J.European heart journal. 1998, Vol 19, Num FEV, pp A62-A65, issn 0195-668X, SUPAConference Paper

Recherche et mise au point de nouvelles thérapeutiques du SIDA (produits agissant sur le métabolisme des neuroeptides opioides et présentant des propriétés immunorestauratrices dans les déficits en cellules CD4+) = Research and development of new therapeutics for AIDS (products acting on the neuroeptide opioid metabolism with immunorestorative properties for CD4+ cell deficits)Bellamy, F; Pascal, M.1989, 32 p.Report

Triglycerides and cardiovascular disease : A focus on clinical trialsCRIQUI, M. H.European heart journal. 1998, Vol 19, Num FEV, pp A36-A39, issn 0195-668X, SUPAConference Paper

Atherogenic, dense low-density lipoproteins : Pathophysiology and new therapeutic approachesCHAPMAN, M. J; GUERIN, M; BRUCKERT, E et al.European heart journal. 1998, Vol 19, Num FEV, pp A24-A30, issn 0195-668X, SUPAConference Paper

Classical risk factors and emerging elements in the risk profile for coronary artery diseaseGENSINI, G. F; COMEGLIO, M; COLELLA, A et al.European heart journal. 1998, Vol 19, Num FEV, pp A53-A61, issn 0195-668X, SUPAConference Paper

The Münster Heart Study (PROCAM) : Results of follow-up at 8 yearsASSMANN, G; CULLEN, P; SCHULTE, H et al.European heart journal. 1998, Vol 19, Num FEV, pp A2-A11, issn 0195-668X, SUPAConference Paper

Triglyceride-rich lipoproteins and progression of atherosclerosisHODIS, H. N; MACK, W. J.European heart journal. 1998, Vol 19, Num FEV, pp A40-A44, issn 0195-668X, SUPAConference Paper

  • Page / 1